The original study executed between 2002-2004 was an interventional trial in which 20, healthy, normal-weight female subjects were randomized to a four-day fast plus daily subcutaneous injections of leptin or a four day fast plus daily subcutaneous injections of a placebo. The primary endpoints were gonadotropin pulsatility, TSH secretion and thyroid function, and cortisol secretion. The current study is a secondary analysis focussed on the placebo group which underwent a four-day fast. The study is looking at the effects of fasting on gut-derived hormones and inflammatory markers in healthy, normal-weight women. The hypothesis for this secondary analysis was that four days of fasting would augment levels of orexigenic gut-derived hormones and suppress levels of anorexigenic gut-derived horomones, while suppressing secretion of inflammatory cytokines.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
DOUBLE
Enrollment
20
Leptin 0.05 mg/kg sc daily in divided doses (0800, 1400, 2000, and 0200h) for four days.
Complete fasting, save for water and multivitamin, for four days.
Massachusetts General Hospital
Boston, Massachusetts, United States
Massachusetts Institute of Technology
Cambridge, Massachusetts, United States
Hormone levels change from baseline.
Original study looking at gonadotropin pulsitility, TSH secretion and thyroid function, and cortisol secretion. Present study looking at gut-hormone secretion.
Time frame: Change from baseline after 4 days of intervention.
Levels of inflammatory cytokines change from baseline.
Time frame: Change from baseline after 4 days of intervention.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.